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ABSTRACT 
 
Ca2+ mediated mitochondrial permeability transition (mPT) is the final common pathway of 
stress-induced cell death in many major pathologies, but its regulation in intact cells is poorly 
understood. Here we report that the mitochondrial carrier SCaMC-1/SLC25A24 mediates ATP-
Mg2-/Pi2- and/or HADP2-/Pi2- uptake into the mitochondria following cytosolic [Ca2+] rises. ATP 
and ADP contribute to Ca2+ buffering in the mitochondrial matrix, resulting in desensitization of 
the mPT. Comprehensive gene expression analysis showed that SCaMC-1 overexpression is a 
general feature of transformed and cancer cells. The knockdown of the transporter led to vast 
reduction of mitochondrial Ca2+ buffering capacity and sensitized cells to mPT mediated 
necrotic death triggered by oxidative stress and Ca2+ overload. These findings revealed that 
SCaMC-1 exerts a negative feedback control between cellular Ca2+ overload and mPT 
dependent cell death, also suggesting that the carrier might represent a novel target for cancer 
therapy. 
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Abbreviations: [Ca2+]cyt, cytosolic [Ca2+]; [Ca2+]m, mitochondrial [Ca2+]; ANT, adenine 
nucleotide translocator; BKA, bongkrekic acid; CAT, carboxyatractyloside; CRC, Ca2+ 
retention capacity; CsA, cyclosporin A; CyP-D, cyclophilin D; cytAEQ, cytosolic aequorin; ER, 
endoplasmic reticulum; IC, intracellular; IMM, inner mitochondrial membrane; IP3, inositol 
1,4,5 trisphosphate; MCU, mitochondrial Ca2+ uniporter; mPT, mitochondrial permeability 
transition; mPTP, mitochondrial permeability transition pore; mtAEQmut, low affinity 
mitochondrial aequorin; mtAEQwt, mitochondrial aequorin; RR, ruthenium red; ROS, reactive 
oxygen species; VDAC, voltage dependent anion channel; ΔΨ, mitochondrial membrane 
potential. 
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INTRODUCTION 
 
ATP generation by aerobic glycolysis is indispensable for the survival and proliferation of many 
tumour cell types, associated with resistance to stress induced apoptotic and necrotic death.1,2 In 
many cell death models, mPT plays a central role in permeabilizing the inner mitochondrial 
membrane (IMM), leading to necrotic cell death.3 The mPT is triggered by the formation of a 
large (cutoff  ~1.5 kD), non-specific pore (mPTP) in the IMM under conditions of Ca2+ overload 
and/or oxidative stress. mPTP opening dissipates the mitochondrial membrane potential (ΔΨ) 
and can be associated with mitochondrial swelling, particularly under in vitro conditions.4 
Although the molecular composition of the mPTP is still debated, pharmacological and genetic 
evidence strongly supports its implication in cell death in a wide range of pathologies.5 
Accordingly, the resistance of tumour cells to death could be explained by decreased probability 
of mPTP opening. Indeed, it has been suggested that Bcl-2 overexpression or reduction of 
Bax/Bak expression can mediate protective effect by diminishing mitochondrial Ca2+ load from 
the endoplasmic reticulum (ER) Ca2+ store.6 In addition, direct modification of putative mPTP 
components, such as hexokinase II binding to the VDAC7 and dephosphorylation of cyclophilin 
D (CyP-D)8 have also been shown to reduce the sensitivity of mPTP formation to elevations of 
[Ca2+]m. However, modification of the mPT is not essential for mediating cancer cell 
protection,9 and no intrinsic mitochondrial factor has been described so far contributing to the 
development of resistance to mPT in cancer cells.  
The net mitochondrial content of adenine nucleotides is central to the regulation of Ca2+ 
induced mPT in isolated organelles, but the underlying mechanisms remained unclear.10 The 
adenine nucleotide translocator (ANT) of the IMM exchanges ATP4- for ADP3-, but does not 
change the total matrix ATP/ADP/AMP content. The net content of adenine nucleotides may 
rather be determined by the ATP-Mg/Pi transporter, which mediates a reversible, electroneutral 
exchange of ATP-Mg2- or HADP2- for HPO42-, stimulated by extramitochondrial Ca2+.11 
Recently, the genes encoding this transporter have been identified. There are four paralogues in 
mammals, SCaMC-1/SLC25A24, SCaMC-2/SLC25A25, SCaMC-3/SLC25A23 and SCaMC-3-
like/SLC25A41.12,13 The transporter consists of a C-terminal domain comprising 6 
transmembrane helices homologous to the mitochondrial carrier proteins,14 and an N-terminal 
domain with Ca2+ binding EF hands,15 which confers Ca2+ sensitivity to the carrier.11,16 These 
properties of the carrier prompted us to investigate the role it might play in regulating Ca2+ 
retention capacity (CRC) of mitochondria and mPTP formation in intact cells. 
Here we report that SCaMC-1 is the dominant isoform of the ATP-Mg/Pi carrier in cancer 
cells and highly overexpressed in a series of in vivo tumours and cell lines. We found that 
cytosolic Ca2+ mediated uptake of ATP/ADP by SCaMC-1 increases intramitochondrial Ca2+ 
buffering, and thus contributes to the resistance to mPT in tumour cells.
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RESULTS AND DISCUSSION 
 
SCaMC-1 is highly expressed in tumours and cancer cell lines, and mediates Ca2+ 
dependent ATP-Mg and ADP uptake into mitochondria  
 
First, using western blot, immunofluorescence and in silico approaches we showed that 
SCaMC-1 is the dominant and highly expressed isoform of ATP-Mg/Pi carrier family in a wide 
range of tumours, cancer cell lines and highly proliferative immortalized cells (Fig. 1A-C, Fig. 
S1). Therefore, in order to study the role of SCaMC-1 in mitochondrial adenine nucleotide 
transport and cancer cell fate, we generated stable SCaMC-1-knock-down cell lines using COS-
7 and 143B parental lines (Fig. 1D-G). In the SCaMC-1-knock-down (SCaMC-1-KD) COS-7 
and 143B clones, the expression was reduced to 29.6 ± 3.8% and 41.7 ± 5.0%, respectively (Fig. 
1F).  
Next, in order to evaluate mitochondrial adenine nucleotide transport in the parental and 
SCaMC-1-KD clones, cells were transiently or stably transfected with mitochondrial matrix 
targeted luciferase to measure mitochondrial ATP levels in digitonin-permeabilized cells or 
isolated mitochondria.17 Following cell permeabilization in an intracellular (IC) buffer 
supplemented with luciferin, added ATP was imported into the mitochondria (Fig. 2). Under 
Ca2+ free conditions the uptake of ATP was completely inhibited by 10 μM 
carboxyatractyloside (CAT), indicating that it was mediated entirely by ATP/ADP exchange 
through ANT. Ca2+-independent ATP import was identical in parental and SCaMC-1-KD cells 
(Fig. 2A). However, in the presence of 100 μM Ca2+, ATP was rapidly imported into the 
mitochondrial matrix even in the presence of CAT (Fig. 2B). The transport was activated by 
extramitochondrial Ca2+, as 200 nM ruthenium red (RR) was present in all the experiments to 
prevent Ca2+ uptake through the mitochondrial Ca2+ uniporter (MCU). Under these conditions, 
ADP uptake was also observed, as measured after its conversion to ATP due to oxidative 
phosphorylation in the matrix (Fig. 2C, Fig. S2A)16. Chelation of Mg2+ (with 1 mM EDTA) 
reduced ATP uptake rate (not shown). The dependence of CAT-insensitive ATP transport on 
extramitochondrial [Ca2+] was determined on isolated mitochondria using a mitochondrial 
luciferase expressing COS-7 cell line, showing a half maximal activation at [Ca2+] = 12.7 ± 5.3 
μM (Fig. 2D,F). Pi addition reversed the activity of the transporter (Fig. 2E), with a similar Ca2+ 
dependence. These results confirmed that these cells express a bona fide Ca2+-dependent ATP-
Mg/Pi carrier, mediating the exchange of ATP-Mg and free ADP to Pi.18 
Importantly, the CAT-insensitive/Ca2+-dependent ATP-Mg/ADP transport was strongly 
reduced in SCaMC-1-KD cells (Fig. 2B,C; ATP: to 56 ± 8%, ADP: to 55 ± 5% of the control 
rate) to an extent similar to the reduction of SCaMC-1 expression, demonstrating that SCaMC-1 
mediates ATP-Mg/Pi transporter activity facilitated by extramitochondrial [Ca2+].  
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SCaMC-1 protects cancer cells from oxidative stress induced death 
 
High expression levels of SCaMC-1 in tumours and cancer cell lines suggested that the carrier 
confers selective advantage to proliferation either by altering cellular metabolism, or by 
mediating protection against cell death. We observed no effect on cellular energy metabolism 
and proliferation (see Fig. S3). Thus next, in order to test whether SCaMC-1 plays a role in 
modulating cell death pathways, control and SCaMC-1-KD were exposed to (i) oxidative stress 
by H2O2 or menadione treatment, leading to mitochondrial Ca2+ overload, mPT and necrosis or 
(ii) staurosporine, triggering the intrinsic pathway of apoptosis. As shown in Fig. 3A-C, reduced 
expression of SCaMC-1 rendered cells more susceptible to oxidative stress induced cell death 
(Fig. 3A,B), while had no effect on apoptosis induced by staurosporine (Fig. 3C, Fig. S4A). 
These data indicated that high expression levels of SCaMC-1 confer resistance specifically to 
mPT-dependent cell death. 
In order to directly demonstrate the effect of SCaMC-1 silencing on mPT in intact cells, we 
studied Ca2+ and reactive oxygen species (ROS) mediated mitochondrial depolarization using 
confocal microscopy, and a previously established model of phototoxicity.19 Following TMRM 
loading, cells were illuminated with high laser power, which leads to the local generation of 
ROS in the mitochondria. ROS mediated Ca2+ release from the ER results in mitochondrial Ca2+ 
overload and mPT, visualized by the loss of TMRM. As shown on Fig. 3D, illumination of 
parental COS-7 cells had no effect on ΔΨm, while it led to the complete loss of ΔΨm in SCaMC-
1-KD cells. The effect was Ca2+ dependent, since it was completely prevented by in Ca2+-free 
medium (in the presence of 100 μM EGTA) and by depleting the internal Ca2+ stores with 
thapsigargin (1 μM). Moreover, the addition of cyclosporin A (CsA) and bongkrekic acid 
(BKA), inhibitors of mPT,20 prevented mitochondrial depolarization in SCaMC-1-KD cells, 
confirming that it was indeed due to mPT. 
Finally, to test whether the high level of SCaMC-1 expression is indeed responsible for 
protection against mPT-dependent cell death, we (i) rescued the expression of SCaMC-1 in 
SCaMC-1-KD 143B cells, using a mutant cDNA containing synonymous mutations (SCaMC-
1*), and (ii) overexpressed the protein in liver clone 9 cells with low levels of endogenous 
SCaMC-1 (Fig. S1). Re-expression of SCaMC-1 in SCaMC-1-KD 143B cells (Fig. 3E), as well 
as its overexpression in both a transient (Fig. 3E) or stable (Fig. 3F) manner in clone 9 cells 
rendered cells more resistant to H2O2 or C2-ceramide induced cell death.21 These results 
confirmed that SCaMC-1 mediates protection against mPT induced cell death. 
 
SCaMC-1 mediated ATP/ADP uptake controls mitochondrial Ca2+ buffering capacity 
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Elevation of the mitochondrial matrix free [Ca2+] is the most potent inducer of mPT. To 
determine the effect of SCaMC-1 on cellular and mitochondrial Ca2+ handling in intact cells, we 
measured agonist-evoked cytosolic and mitochondrial Ca2+ transients in cells transiently 
transfected with a cytosolic aequorin (cytAEQ) or a mitochondrial aequorin (mtAEQwt) probe, 
respectively.22  
After reconstitution of the probe with the aequorin cofactor coelenterazine, COS-7 cells 
were stimulated with 100 μM ATP, an agonist acting on G-protein-coupled receptors and 
leading to the production of IP3. The consequent Ca2+ release from the intracellular stores 
induced a cytosolic Ca2+ transient, which was identical in control and SCaMC-1-KD cells (Fig. 
4A, left panel). However, intriguingly, mitochondrial Ca2+ uptake was increased almost three 
times in SCaMC-1-KD cells as compared to controls (Fig. 4B, left panel). Similar results were 
obtained when parental and SCaMC-1-KD 143B cells were stimulated with 100 μM histamine 
(Fig. 4A,B, right panels).  
Mitochondrial free [Ca2+] is determined by the balance between Ca2+ influx into and Ca2+ 
extrusion from the organelle, as well as by Ca2+ buffering in the matrix. Thus, in order to 
characterize the mechanism by which SCaMC-1 activity affects [Ca2+]m, we determined 
mitochondrial Ca2+ influx and efflux rates in isolated mitochondria or permeabilized cells. 
When measured in the mitochondrial matrix in permeabilized cells expressing the low affinity 
mitochondrially targeted aequorin probe (mtAEQmut), the addition of the same amount of 
extramitochondrial Ca2+ (10 μM) caused significantly greater elevation in [Ca2+]m in both COS-
7 and 143B SCaMC-1-KD cells as compared to their parental counterpart (Fig. 4C). However, 
when measured in the extramitochondrial space with the fluorescent Ca2+ sensitive dye 
Calcium-Green, mitochondria from both the parental and SCaMC-1-KD cells took up the same 
amount of Ca2+ with the same rate (Fig. 4D). Ca2+ efflux was measured after inhibition of Ca2+ 
uptake with RR. In that situation, the rate of Ca2+ efflux depends only on the matrix free [Ca2+]. 
After loading 143B mitochondria with Ca2+ in the presence of 1 mM ATP-Mg, RR was added. 
Fig. 4E shows that the efflux of Ca2+ (both Na+-independent and Na+-dependent) was more 
rapid in SCaMC-1-KD mitochondria than in controls, indicating (i) higher free [Ca2+] following 
Ca2+ load in mitochondria lacking SCaMC-1 mediated ATP uptake, and (ii) normal activity of 
the efflux machineries. These results show that increased [Ca2+]m in the mitochondria of 
SCaMC-1-KD cells is not the consequence of increased Ca2+ uptake or reduced Ca2+ efflux, but 
rather reflects reduced Ca2+ buffering capacity in the matrix. 
Ca2+ buffering in the mitochondrial matrix is principally achieved by the formation of 
insoluble Ca2+-Pi precipitates.23 A higher level of Ca2+ precipitation in control mitochondria 
could be explained if the adenine nucleotides transported by SCaMC-1 facilitate the 
precipitation of Ca2+ and Pi in the matrix, as has been suggested previously.24 The formation of 
Ca2+-Pi precipitates can be measured by the apparent mitochondrial contraction (an increase in 
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light scattering measured as absorbance at 540 nm) immediately following Ca2+ uptake.23,25 
Indeed, mitochondria of 143B cells displayed apparent contraction when Ca2+ was added to the 
medium, which was inhibited by the addition of RR, preventing Ca2+ entry through the MCU. 
Moreover, the initial increase in absorbance in the presence of ATP-Mg was significantly higher 
in the mitochondria of control than that of SCaMC-1-KD 143B cells (0.041 ± 0.006 absorbance 
units per min compared to 0.018 ± 0.003, respectively mean ± SEM, n=3, p = 0.048; not 
shown). These results suggest higher efficiency of Ca2+-Pi precipitate mediated Ca2+ buffering 
in the presence of SCaMC-1. 
 
SCaMC-1 increases mitochondrial Ca2+ retention capacity and reduces probability of Ca2+ 
mediated mPTP opening 
 
Regulation of Ca2+-dependent mPTP opening by low micromolar concentrations of ATP/ADP is 
well established,26 and is mediated by a nucleotide induced switch in the conformation of ANT. 
However, higher concentrations of adenine nucleotides, in the physiological millimolar range, 
are also able to prevent mPTP formation.27 Thus we tested whether Ca2+ mediated uptake of 
ATP-Mg/ADP by SCaMC-1 can affect mitochondrial CRC, a measure of the amount of Ca2+ 
required in order to trigger mPT. 
CRC was studied by monitoring Ca2+ uptake into mitochondria using Calcium-Green to 
measure [Ca2+] in the buffer. Permeabilized cells were treated with sequential Ca2+ pulses, and 
Ca2+ uptake into mitochondria was measured as a drop in the fluorescence. mPTP opening was 
detected as a steady increase of fluorescence due to Ca2+ release from mitochondria. Other 
organelles, such as the ER do not contribute significantly to Ca2+ uptake, as RR completely 
inhibited uptake (not shown). As summarized in Fig. 5A, permeabilized control and SCaMC-1-
KD COS-7 cells display a similar mitochondrial CRC both in the absence of adenine 
nucleotides and in the presence of low ADP (100 μM). In both lines, 100 μM ADP increased the 
CRC only slightly (less than 10 % on COS-7 cells, p>0.05; 20% in 143B cells, p<0.05, not 
shown), probably by interacting with the ANT and triggering the ‘m’ conformation of the 
carrier, as previously demonstrated in liver and brain mitochondria.20 Most importantly, 
however, in the presence of 1 mM ATP or 2 mM ADP, control COS-7 or 143B cells displayed a 
pronounced increase in the threshold for mPTP opening compared to SCaMC-1-KD cells, 
whose CRC was practically identical to that measured in the presence of 100 μM ADP. The 
presence of Mg2+ was essential for the protective effect of ATP, but not for that of ADP, 
consistently with the substrate specificity of SCaMC-1. The same results were obtained in 
isolated mitochondria from COS-7 or 143B cells (Fig. 5B,C), as mitochondria from control cells 
are able to take up more Ca2+ in the presence of 1 mM ATP or 2 mM ADP than SCaMC-1-KD 
mitochondria before release of accumulated Ca2+ by mPTP opening.  
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 mPTP opening can also be studied by monitoring mitochondrial swelling. Fig. 5D shows 
that Ca2+ addition to COS-7 mitochondria in the presence of ATP initially caused contraction, 
while further additions led to swelling (a decrease in absorbance). The number of Ca2+ additions 
needed to trigger swelling in the presence of 2 mM ATP was always higher in control 
mitochondria as compared to SCaMC-1-KD mitochondria. On the other hand, swelling was 
identical in the absence of nucleotides. Similar results were obtained in 143B isolated 
mitochondria (Fig. 5E).  
In the presence of 5 μM CsA, an inhibitor of mPT, the CRC was enhanced in permeabilized 
cells and isolated COS-7 mitochondria (Fig. 5A,B), and mitochondrial swelling was inhibited 
(Fig. 5D), demonstrating that the effects observed were due to mPTP opening. CsA produced 
these effects in both control and SCaMC-1-KD mitochondria, but the differences between both 
lines in the presence of 1 mM ATP were still observed. On the other hand, 5 μM CAT, a 
stimulator of mPT, greatly reduced the CRC in both control and SCaMC-1-KD permeabilized 
cells, but a difference between the two cell lines in the presence of 1 mM ATP was still 
observed (Fig. 5A). The increase in CRC by 1 mM ATP in the presence of CAT in control cells 
proves that the effect of high concentrations of adenine nucleotides was indeed independent of 
the ANT, as had been suggested previously.26 Furthermore, in the presence of 5 μM BKA, 
another ANT inhibitor, the differences between both lines obtained at 1 mM ATP were still 
present (Fig. 5A).  
Interestingly, 143B permeabilized cells and isolated mitochondria were largely unaffected 
by CsA (Fig. 5C, Fig. S4B). This is not due to a lower expression of CyP-D (Fig. 1E), the 
regulatory component of the pore that is targeted by CsA, an argument which is used to explain 
the CsA-insensibility of brain mitochondria.28 An alternative explanation is that 143B are 
tumour cells, whereas COS-7 are merely immortalized cells. Tumour cells display a constitutive 
activation of the ERK pathway, which has been suggested to dephosphorylate and inactivate 
CyP-D,8 and thus, although present, CyP-D may be inactive in 143B mitochondria. In order to 
study this possibility first the phosphorylation state of CyP-D was assayed by the Mn2+-Phos-tag 
SDS-PAGE technique. In FLAG-CyP-D overexpressing COS-7 cells, several shifted CyP-D 
bands were observed, demonstrating the phosphorylated status of the protein (Fig. 5F). 
Importantly, these bands were almost completely missing in FLAG-CyP-D overexpressing 
143B cells in spite of the equal expression of CyP-D. In addition, 143B cells showed a 
constitutive phosphorylation of ERK, whereas COS-7 cells did not (Fig. 5F). In this pathway, 
ERK was shown to phosphorylate and inactivate GSK-3β, the putative CyP-D kinase. Indeed, 
we found that that GSK-3β was phosphorylated in 143B cells, but not in COS-7 cells (Fig. 5F). 
These results suggest that in 143B cells, as a result of a constitutively active ERK/GSK-3β 
pathway, CyP-D is mostly dephosphorylated and thus inactive. Conversely, in COS-7 cells 
CyP-D is partially phosphorylated and active due to the lack of ERK activation.    
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In summary, these results provide evidence that adenine nucleotides regulate mPTP opening 
independently of the ANT, via a lower affinity site, reflecting the activity of the ATP-Mg/Pi 
carrier. The modification of the mitochondrial adenine nucleotide content by the ATP-Mg/Pi 
carrier regulates the CRC and mPTP opening, probably by modifying the formation of Ca2+-Pi 
precipitates and thus altering the Ca2+ buffering capacity of the mitochondrial matrix. 
 
CONCLUDING REMARKS 
 
Altogether, our data fully support a model where SCaMC-1 is responsible for a cytoprotective 
mechanism by mediating (i) ATP/ADP uptake in the mitochondrial matrix, triggered by 
increases of [Ca2+]cyt; (ii) increased mitochondrial Ca2+ buffering capacity due to elevated 
adenine nucleotide levels; (iii) desensitization of Ca2+ mediated mPT. This pathway represents a 
novel mechanism promoting cancer cell survival under stress conditions. 
High levels of SCaMC-1 were previously found by screening approaches in colorectal 
carcinomas,29 breast cancer30 and in several cancer cell lines.15,31 Our in silico studies confirmed 
and extended these findings to 67 different tumour types where SCaMC-1 expression 
significantly exceeded its expression in their normal tissue counterpart. Importantly, this pattern 
was specific to the SCaMC-1 isoform, which has an order of magnitude higher transport activity 
than SCaMC-3.18 This suggested that the benefit conferred by SCaMC-1 overexpression implies 
a high rate of transport of adenine nucleotides in the mitochondrial matrix under conditions of 
pathologically elevated [Ca2+]cyt. The S0.5 for Ca2+ of SCaMC-1 was found to be 12.7 μM, 
adequate to respond to changes in the [Ca2+]cyt that are transmitted to the mitochondria through 
the MCU during Ca2+ overload both under physiological and pathological conditions. Indeed, 
SCaMC-1 expression was not essential for cellular proliferation, rather was required for 
protection against oxidative stress and Ca2+ overload induced cell death. This resembles the 
effect of Bcl-2 overexpression,32 Bax and Bak downregulation,6 Bad phosphorylation,33 
hexokinase II binding to mitochondria7 and the constitutive activation of the ERK pathway.8 
Distinct from some of these studies, however, is that the role of SCaMC-1 was exclusive to 
mPT driven cell death, since no effect was observed on cell death induced by staurosporine. 
Altogether, the selective overexpression of SCaMC-1 over normal tissues and its specific role in 
protecting from oxidative stress induced cell death indicate that selective ablation of SCaMC-1 
function might represent a novel strategy to abolish tumour growth in a wide range of cancers. 
 Low concentrations of adenine nucleotides (≈ 100 μM) inhibit mPTP opening in isolated 
liver and brain mitochondria,26 most likely by conformational changes  triggered by binding to 
high affinity sites (Kd ≈ 5 - 10 μM) of the ANT.20 However, adenine nucleotides in the 
millimolar, physiological range also exhibit potent mPT inhibiton, even in the presence of ANT 
inhibitors.10,27,34 The site of this ANT-independent protection remained unexplained.35 Here we 
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found that SCaMC-1, which displays binding sites for adenine nucleotides in this affinity range 
(Kd ≈ 0.2 - 0.5 mM) is able to mediate this effect.  
While the mechanism by which matrix adenine nucleotides protect from mPT is not 
completely understood, our data clearly suggest that altered mitochondrial Ca2+ handling plays a 
major role in the effect. The lack of ATP/ADP uptake in the mitochondria of SCaMC-1-KD 
cells led to a vast increase of free matrix [Ca2+] following activation of cellular Ca2+ signalling 
pathways, as compared to cells with high SCaMC-1 expression levels.  
Accordingly, we propose that the SCaMC-1 mediated adenine nucleotide load in the 
mitochondrion buffers matrix free [Ca2+], preventing mitochondrial Ca2+ overload during 
oxidative stress and preventing mPT induction. As a major route of mitochondrial Ca2+ 
buffering, Ca2+ and Pi form amorphous Ca3(PO4)2 precipitates in the matrix.23,25 It has long been 
suggested that the presence of adenine nucleotides in the mitochondrial matrix is essential for 
this process, either by stabilizing the Ca2+-Pi deposits or by priming their precipitation.24 As a 
result, mitochondrial Ca2+-Pi precipitates contain adenine nucleotides,36 and ATP may account 
for as much as 7 % of the dry weight of some Ca2+-Pi precipitates.37 Interestingly, Ca2+-Pi 
precipitates in isolated mitochondria also contain Mg2+ when Ca2+ loading was performed in the 
presence of ATP, but not in the presence of ADP,25 which matches the substrate specificity of 
the ATP-Mg/Pi carriers.11,18  
The protective effect of increasing amounts of matrix Ca2+-Pi precipitates has already been 
observed, particularly in cell death models mediated entirely by Ca2+ overload, such as 
glutamate excitotoxicity in primary neurons.38 Our findings extend these observations to cancer 
cells, and provide direct demonstration of the effect of SCaMC-1 knock-down mediated adenine 
nucleotide depletion on mitochondrial Ca2+ handling.  
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EXPERIMENTAL PROCEDURES 
 
Cell culture, transfection, generation of SCaMC-1-KD and mitochondrial luciferase 
expressing clones 
COS-7 cells, liver clone 9 cells and 143B osteosarcoma cells were cultured in Dulbecco’s 
modified Eagle’s medium supplemented with 5 % inactivated fetal bovine serum (Invitrogen) at 
37 °C in a 5 % CO2 atmosphere. For transfections, the LipofectAMINE reagent (Invitrogen) was 
used as previously described.15 Details of the constructs and generation of SCaMC-1-KD 
clones, cells overexpressing SCaMC-1 or cells stably expressing mitochondrially targeted 
luciferase are described in the Supplementary Methods section.  
 
Immunofluorescence and western blotting 
Immunofluorescent stainings were performed as described previously.15 Anti-SCaMC-1 
antibodies were diluted 1:400. Fluorescence microscopy was performed using an Axiovert 
epifluorescence microscope (Carl Zeiss) at a nominal magnification of X100. 
For western blotting, total homogenates and mitochondrial-enriched fractions were obtained 
from cells and mouse tissues as described15 and analyzed by western blotting (for details see 
Supplementary Methods). To determine the phoshorylation status of CyP-D, Mn2+-Phos-tag 
SDS-PAGE was performed39. Poly-acrylamide gels were supplemented with 200 μM MnCl2  
and the Phos-tag reagent (Nard Institute, Japan). Phosphorylated proteins bind to the Phos-tag, 
and thus are delayed in the gel and separated from unphosphorylated proteins. After 
electrophoresis, the gels were washed with transfer buffer containing 1 mM EDTA and then 
with transfer buffer without EDTA according to the manufacturer’s protocol, before transfer to 
PVDF membranes. Membranes were probed with CyP-D antibodies. 
 
Measurements of mitochondrial Ca2+ uptake and swelling on isolated mitochondria or 
permeabilized cells 
Mitochondria were isolated by homogenization and differential centrifugation according to 
standard protocols. Mitochondrial Ca2+ uptake was measured in the presence of the Ca2+-
sensitive fluorescent probe Calcium-Green 5N (0.1 μM, excitation 506 nm, emission 532 nm) 
using digitonin-permeabilized cells or isolated mitochondria (for details see Supplementary 
Methods). 
 
Measurement of cellular respiration and ΔΨm  
Cell respiration was measured using a Seahorse XF24 Extracellular Flux Analyzer (Seahorse 
Bioscience, Billerica, MA, USA; for details see Supplementary Methods). ΔΨm was measured 
with the fluorescent lipophilic cationic dye tetramethylrhodamine methyl ester (TMRM). Cells 
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were stained with 200 nM TMRM for 10 min, and red fluorescence was measured by flow 
cytometry.  
10% laser power of the 543 HeNe laser line on the Zeiss 510 confocal system was used to 
induce mPT, which was detected by the loss of TMRM signal, as previously described.19 Cells 
were preincubated with 100 nM TMRM for 20 min at 37 ºC in a modified Krebs-Ringer buffer 
(KRB; 135 mM NaCl, 5 mM KCl, 1 mM MgSO4, 0.4 mM K2HPO4, 1 mM CaCl2, 5.5 mM 
glucose, 20 mM HEPES, pH 7.4). TMRM was then present throughout the subsequent 
measurements. Confocal images were obtained using a Zeiss 510 LSM/META system using a 
x40 oil-immersion objective. For detection a 560-nm long-pass filter was used.  
 
Luminescent detection of cellular [Ca2+] and [ATP] 
Cytosolic and mitochondrial [Ca2+] in intact cells was measured 48 hours after transient 
transfection with cytAEQ and mtAEQwt probes as previously described.22 To measure 
mitochondrial ATP levels in permeabilized cells, experiments were carried out 24 h after 
transient transfection with mitochondrial luciferase.17 For experimental details see 
Supplementary Methods.  
 
Cell death detection 
Cells were incubated with H2O2, menadione or staurosporine for the time periods indicated in 
the figure legends and cell death was evaluated by previously described methods5,7,8,21: (i) by 
microscopy after loading with 1 μM Calcein-AM to stain alive cells and 2 μM PI to stain the 
nuclei of dead cells; (ii) by flow cytometry after loading with 2 μM PI to stain the nuclei of dead 
cells; (iii) by flow cytometry after incubation with 200 nM TMRM to detect mitochondrial 
depolarization and FITC-conjugated Annexin-V (Sigma) to detect phosphatidylserine exposure 
on the cell surface and (iv) by flow citometry using the Annexin V-FITC Apoptosis Detection 
Kit (Sigma). 
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FIGURE LEGENDS 
 
Fig. 1. Expression of SCaMC isoforms in normal and tumour tissues. Generation of 
SCaMC-1-KD cell lines. 
A) Immunoblot analysis of SCaMC-1 and SCaMC-3 expression in total homogenates from 
mouse tissues and from COS-7 and 143B cells. Antibodies against Hsp60 were used as loading 
control. B: Brain; L: Liver; FL: fetal liver; S: spleen; K: kidney; H: heart; C: colon; SI: small 
intestine; LU: lung; M: muscle; T: testis; WF: white fat; BF: brown fat. B) Disease summary for 
SCaMC family (SCaMC-1, SCaMC-2, SCaMC-3) analysed by the Oncomine database 
(www.oncomine.org). Table shows the number of significant unique analyses across the whole 
oncomine database (including 93 datasets curated for cancer vs.normal analysis) with 
overexpression (red) or underexpression (blue). Cell color is determined by the best gene rank 
percentile for the analyses within the cell. SCaMC-1 shows overexpression/underexpression 
ratio of 67/33 from 192 analyses, in contrast to 14/28 from 125 and 19/65 from 165 for SCaMC-
2 and SCaMC-3, respectively. A threshold significance value of 0.05 was used including setting 
to ‘ALL’ for fold change, gene rank thresholds and data types. For links to the analyses see 
supplementary text. Right panel:  Comparison of SCaMC-1/SLC25A24 expression across 67 
cancer vs. normal analyses including over-expression (mRNA) and copy number gain (DNA). 
The rank for a gene is the median rank for that gene across each of the analyses. The p-Value of 
the median-ranked analysis is shown. For references and link to analysis see supplementary text. 
C) Protein expression profiles of SCaMC-1 (upper panel) and SCaMC-2 (lower panel) obtained 
in the Human Protein Atlas database (www.proteinatlas.org) based on immunohistochemistry 
on cancer samples.40 The color determines the percentage of cancer samples in the database with 
a given expression level. SCaMC-3 is not available in the database. D-F) Immunoblot to detect 
SCaMC-1 and other SCaMC isoforms in total homogenates (D) or isolated mitochondria (E) 
from COS-7 and 143B control (C) and SCaMC-1-KD (KD) cells. Mouse brain (B) and liver (L) 
mitochondria are also shown in (E). Antibodies against Hsp60, GAPDH or CyP-D were used as 
loading control. F) Quantification of the expression of SCaMC-1 or Hsp60 compared to 
GAPDH (mean ± SEM, n=5). G) Immunofluorescence in COS-7 and 143B control and 
SCaMC-1-KD cells using anti-SCaMC-1 antibodies.  
 
Fig. 2. Ca2+-dependent/CAT-insensitive adenine nucleotide uptake through SCaMC-1.  
(A-C) 143B cells transiently expressing mitochondrial luciferase17 were permeabilized and 
100 μM luciferin was added to report mitochondrial ATP levels. Black traces indicate control 
cells, whereas red traces show SCaMC-1-KD cells. A) ANT activity in the absence of Ca2+: the 
medium contained 100 μM EGTA, and 1 mM ATP was added when indicated. The traces 
marked with arrows were obtained from cells treated with 10 μM CAT. B-C) SCaMC-1 
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activity: the medium contained 100 μM Ca2+ and 10 μM CAT, and 1 mM ATP (B) or 2 mM 
ADP (C) were added when indicated. Bar charts indicate transport rate of SCaMC-1-KD (KD) 
cells compared to controls (C) (mean ± SEM, n=6).  
(D-F) To determine the Ca2+ sensitivity of SCaMC-1 mediated ATP/ADP transport, 
mitochondrial ATP changes were measured in isolated mitochondria from COS-7 cells stably 
expressing mitochondrial luciferase after addition of 100 μM luciferin. D) The medium 
contained 10 μM CAT and free Ca2+ at the indicated concentrations, and 1 mM ATP was added 
when indicated. E) Efflux of ATP from mitochondria was triggered with the addition of 10 mM 
Pi followed by different Ca2+ concentrations. The efflux was reverted at the end of the 
experiment by addition of 1 mM ADP. F) Ca2+ activation of CAT-insensitive ATP transport. 
Transport rates were calculated from the slopes in panel D after ATP addition and fit to the 
equation: V = V0 + [(Vmax  - V0) x [Ca2+]N) / (S0.5N + [Ca2+]N)] (where V is transport activity at 
each [Ca2+], V0 is the basal transport rate at [Ca2+] ≈ 0, Vmax is the maximal activity, N is the hill 
coefficient and S0.5 is the Ca2+ concentration which generates half-maximal transport activity). 
Pooled data of 6 independent experiments are shown. 
 
Fig. 3. SCaMC-1 selectively protects from oxidative stress induced cell death.  
A) Left panel: Control and SCaMC-1-KD 143B cells were incubated with H2O2 for 6 h and 
cell death was evaluated by confocal microscopy after 1 μM Calcein-AM and 2 μM PI staining. 
Right panel: Control and SCaMC-1-KD COS-7 cells were incubated with menadione for 2 
hours and cell death was evaluated by flow cytometry after PI staining (Mean ± SEM, n= 6 and 
5, respectively. * p < 0.05) B) Control and SCaMC-1-KD 143B cells were incubated with 1 mM 
H2O2 for 3.5 h or with 100 μM menadione for 1 h and cell death was evaluated by flow 
cytometry after TMRM and annexin V-FITC staining. A representative experiment is shown 
where H indicates the percentage of healthy cells (positive for TMRM and negative for annexin 
V, delimited by the quadrant), D indicates the percentage of dead cells (negative for TMRM and 
positive for annexin V). The number at the bottom of each panel indicates the percentage (mean 
± SEM, n=6) of healthy cells. **p = 0.00031. *p = 0.014. C) Control and SCaMC-1-KD COS-7 
and 143B cells are equally sensitive to 1 μM staurosporine induced cell death. Cells were 
treated with the drug for 0, 16 or 40 h and death was evaluated by flow cytometry after PI and 
annexin V-FITC staining.  D) SCaMC-1-KD cells are more vulnerable to phototoxicity-induced 
oxidative stress. Control and SCaMC-1-KD COS-7 cells were loaded with 100 nM TMRM, 
illuminated with 10% laser power of the 543 nm HeNe line of the confocal system and the 
collapse of the mitochondrial ΔΨ was monitored over time. Lower left panels: SCaMC-1-KD 
cells were treated with 100 μM EGTA and 1 μM thapsigargin. Lower right panels: cell treated 
with 5 μM CsA and 50 μM BKA. Figure shows representative images of at least 3 independent 
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experiments. E) Sensitivity to mPT dependent cell death of SCaMC-1 overexpressing 143B 
SCaMC-1-KD cells (left panel) and liver clone 9 cells (right panel). Cells were transiently 
transfected with GFP, or with GFP and SCaMC-1 and exposed to C2 ceramide or H2O2 for 6 
hours. The graph bar shows the change in percentage of GFP fluorescent cells (as compared to 
total cell number) after the treatment.21 An increase in this percentage compared with control 
transfections indicates protection by SCaMC-1. The right panel shows the increase in SCaMC-1 
expression after the transfection. SCaMC-1*: rescue construct with synonymous mutations (see 
the Supplementary Methods section). F) Control and stable SCaMC-1 overexpresing liver clone 
9 cells were incubated with H2O2 for 3 h and cell death was evaluated by flow cytometry after 
PI staining (Mean ± SEM, n= 3. * p < 0.05). The right panel shows the increase in SCaMC-1 
expression in the stable SCaMC-1 overexpressing clone. 
 
Fig. 4. SCaMC-1 knock-down reduces mitochondrial Ca2+ buffering in intact cells and 
isolated mitochondria.  
Agonist induced Ca2+ rises in cytosol (A) and mitochondria (B) of cells transiently 
expressing cytAEQ and mtAEQwt probes, respectively. Ca2+ signals were induced by ATP in 
COS-7 and by histamine in 143B cells (black: controls, red: SCaMC-1-KD). Bar charts show 
the quantification of the results in control (C) and SCaMC-1-KD cells (KD, mean ± SEM, n=3). 
C) Mitochondrial [Ca2+] of COS-7 (left panel) and 143B (right panel) permeabilized cells after 
addition of 10 μM (free [Ca2+]) Ca2+ to the IC buffer. Bar charts show the quantification of the 
results in control (C) and SCaMC-1-KD cells (KD, mean ± SEM, n=3).  D) Ca2+ uptake rate in 
permeabilized cell and isolated mitochondria, measured by Calcium Green 5N free salt as an 
extramitochondrial Ca2+ indicator. A 20 μM (free [Ca2+]) Ca2+ pulse was added where indicated 
(black: controls, red: SCaMC-1-KD). E) Ca2+ efflux was measured using Calcium Green 5N 
free salt in the extramitochondrial space of isolated 143B mitochondria, in the presence of 1 
mM ATP, followed by loading with 320 nmol of Ca2+ per mg of protein. Where indicated, 200 
nM RR was added to inhibit Ca2+ uptake, followed by the addition of 10 mM NaCl to stimulate 
the Na+/Ca2+ exchanger (black: controls, red: SCaMC-1-KD). Bar chart shows the quantification 
of Na+-independent (white bars) and Na+-dependent (black bars) Ca2+ efflux rates in control and 
SCaMC-1-KD mitochondria (mean ± SEM, n=3 * p < 0.05).  
 
Fig. 5. SCaMC-1 reduces Ca2+ sensitivity of mPT in isolated mitochondria and 
permeabilized cells.  
Ca2+ mediated mPT in control (black traces) and SCaMC-1-KD (red traces) COS-7 (A-B,D) 
and 143B cell (C,E) mitochondria.  
A) Quantification of Ca2+ retention capacity after administration of subsequent Ca2+ pulses 
(20 μM each) to control (white bars) and SCaMC-1-KD (black bars) permeabilized COS-7 cells 
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(0.15 mg total protein/mL). CRC was determined in the presence or absence of adenine 
nucleotides, Mg2+ and inhibitors. The Ca2+ concentration required to open the mPTP is shown. 
(mean ± SEM, n=6-16)  
B,C) CRC was measured in isolated mitochondria in the presence of 1 mM ATP (B) or 2 
mM ADP (C) using the Ca2+ sensitive probe Calcium Green 5N free salt in the 
extramitochondrial space. Experiments started by the addition of mitochondria, followed by 
repetitive Ca2+ pulses (arrows, 20 μM each). The traces marked with a long arrow are in the 
presence of 5 μM CsA. 
D,E) Swelling of isolated mitochondria after subsequent Ca2+ pulses (arrows, 40 μM each) 
was measured as a decrease in light scattering at an absorbance of 540 nm in the presence (left 
panel) or absence (middle panel) of 2 mM ATP. Traces in the right panel were recorded in the 
presence of 2 mM ATP and either 5 μM CsA (D) or 200 nM RR (E).  
F) The ERK pathway is constitutively active in 143B cells, but not in COS-7 cells and 
controls CyP-D phosphorylation. Left panels: Immunoblot against phospho- and total ERK, and 
phospho- and total GSK-3β in total homogenates from COS-7 and 143B cells. Right panel: 
Immunoblot against CyP-D in total homogenates from control or FLAG-CyP-D8 overexpressing 
COS-7 and 143B cells after Mn2+-Phos-tag SDS-PAGE.39 Phosphorylated proteins are shifted 
upwards in the gel compared to unphosphorylated proteins. The same bands were observed 
when anti-FLAG antibodies were used, confirming the specificity of the bands (not shown). 
CyP-D phosphorylation is greatly decreased if the extracts are treated with alkaline phosphatase 
(AP) for 30 minutes (far right lane). 
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